Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Weich

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Arthritis Research & Therapy|February 11, 2026
Establishing C-X-C motif chemokine receptor 4 as a novel imaging target in giant cell arteritisMatthias Fröhlich, Sebastian E Serfling, Michael Gernert, et al.
Clinical Nuclear Medicine|March 22, 2023
Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and TherapyPhilipp E Hartrampf, Aleksander Kosmala, Sebastian E Serfling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2018
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization FrameworkRudolf A Werner, Lilja B Solnes, Mehrbod S Javadi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2025
Diagnostic Performance of [<sup>18</sup>F]PSMA-1007 PET/CT on Proven PSMA-Positive Hepatocellular Carcinoma: A Prospective Clinical StudyKerstin Michalski, Florian P Reiter, Aleksander Kosmala, et al.
Nuclear Medicine Communications|February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cellsAlexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 9, 2023
Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [<sup>18</sup>F]FDGAleksander Kosmala, Johannes Duell, Simone Schneid, et al.
Clinical Nuclear Medicine|September 27, 2023
Somatostatin Receptor-Directed PET/CT Can Differentiate Between Different Subtypes of Head and Neck ParagangliomasYingjun Zhi, Elena Gerhard-Hartmann, Philipp E Hartrampf, et al.
Surgical Endoscopy|July 19, 2022
Evolution of endoscopic vacuum therapy for upper gastrointestinal leakage over a 10-year period: a quality improvement studyStanislaus Reimer, Florian Seyfried, Sven Flemming, et al.
Annals of Nuclear Medicine|August 16, 2018
Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implicationsRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Theranostics|May 23, 2017
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative ApproachRudolf A Werner, Alexander Weich, Takahiro Higuchi, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Arthritis Research & Therapy|February 11, 2026
Establishing C-X-C motif chemokine receptor 4 as a novel imaging target in giant cell arteritisMatthias Fröhlich, Sebastian E Serfling, Michael Gernert, et al.
Clinical Nuclear Medicine|March 22, 2023
Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and TherapyPhilipp E Hartrampf, Aleksander Kosmala, Sebastian E Serfling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2018
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization FrameworkRudolf A Werner, Lilja B Solnes, Mehrbod S Javadi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2025
Diagnostic Performance of [<sup>18</sup>F]PSMA-1007 PET/CT on Proven PSMA-Positive Hepatocellular Carcinoma: A Prospective Clinical StudyKerstin Michalski, Florian P Reiter, Aleksander Kosmala, et al.
Nuclear Medicine Communications|February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cellsAlexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 9, 2023
Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [<sup>18</sup>F]FDGAleksander Kosmala, Johannes Duell, Simone Schneid, et al.
Clinical Nuclear Medicine|September 27, 2023
Somatostatin Receptor-Directed PET/CT Can Differentiate Between Different Subtypes of Head and Neck ParagangliomasYingjun Zhi, Elena Gerhard-Hartmann, Philipp E Hartrampf, et al.
Surgical Endoscopy|July 19, 2022
Evolution of endoscopic vacuum therapy for upper gastrointestinal leakage over a 10-year period: a quality improvement studyStanislaus Reimer, Florian Seyfried, Sven Flemming, et al.
Annals of Nuclear Medicine|August 16, 2018
Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implicationsRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Theranostics|May 23, 2017
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative ApproachRudolf A Werner, Alexander Weich, Takahiro Higuchi, et al.
Pageof 6